The Interstellar: Developing Future Leaders programme has been co-created by Novartis and a steering committee of medical experts, to provide education in rheumatology, support innovative service delivery and facilitate the sharing of clinical excellence to improve patient outcomes in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
Introducing the Interstellar: Developing Future Leaders programme
The Interstellar: Developing Future Leaders programme consists of three workshop-led meetings that provide an enhanced learning opportunity for experienced and future leaders in the field of PsA and axSpA (AS and nr-axSpA), who will help pave the way to advance research and improve patient care in rheumatology.
Members of the Interstellar: Developing Future Leaders programme have the opportunity to meet with rheumatology experts to share knowledge and practical information on best practice approaches to disease management and service delivery.
Interstellar 2020 meetings timeline
Setting the foundations for a strong future in PsA and AS
Nurturing knowledge and communicating with conviction as a leading healthcare professional
Advancing research in PsA and axSpA (AS and nr-axSpA)
Enabling evidence generation and addressing unmet research needs
Leading improvement and innovation in PsA and axSpA (AS and nr-axSpA) clinical practice
Driving change and service optimisation as a team leader